Lineage Cell Therapeutics, Inc. Common Stock · Depreciation & Amortization

Latest reported$739.00Kperiod endingJun 30, 2026

LCTX Depreciation & Amortization ($0.00 → $739.00K)

Annual Depreciation & Amortization

High-resolution chart · PNG

LCTX depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	699,000
Dec 31, 2024	609,000
Dec 31, 2023	692,000
Dec 31, 2022	727,000
Dec 31, 2021	873,000
Dec 31, 2020	2,039,000
Dec 31, 2019	3,000,000
Dec 31, 2018	3,273,000
Dec 31, 2017	3,296,000
Dec 31, 2016	4,757,000
Dec 31, 2015	6,334,000
Dec 31, 2014	8,410,341
Dec 31, 2013	3,952,475
Dec 31, 2012	2,833,432
Dec 31, 2011	2,366,531
Dec 31, 2010	928,776
Dec 31, 2009	34,591
Dec 31, 2008	16,745
Dec 31, 2007	-189,230
Dec 31, 2006	26,511
Dec 31, 2005	6,374
Dec 31, 2004	1,048,815
Dec 31, 2003	810,584
Dec 31, 2002	506,746
Dec 31, 2001	295,605
Dec 31, 2000	75,458
Dec 31, 1999	59,540
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	0
Jun 30, 1994	0
Jun 30, 1993	0
Jun 30, 1992	0